中国透云(01332.HK)附属建多项设施 涉资逾1,000万人币
中国透云(01332.HK)公布,附属山西透云生物科技与承建商订协议,兴建生产莱茵衣藻、微藻及相关产品於项目地盘建设一间占地1,476.37平方米的动力车间及两间占地合共83.41平方米的警卫室,涉资354.58万元人民币(下同)。
另外,公司亦就兴建生产莱茵衣藻、微藻及相关产品於项目地盘不同位置建设占地合共3,309.26平方米的各类型水池及设施,包括消防水池、循环水池、事故池、污水池、生产水池、生活水池及污水处理池,与承建商订协议,涉资661.85万元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.